These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12940611

  • 1. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 2. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
    Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, Swartz RD.
    J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
    [Abstract] [Full Text] [Related]

  • 3. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 4. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA.
    Pharmacotherapy; 1997 Oct; 17(2):256-62. PubMed ID: 9085316
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 6. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
    Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ.
    Am J Kidney Dis; 1995 Sep; 26(3):469-74. PubMed ID: 7645555
    [Abstract] [Full Text] [Related]

  • 8. Removal of vancomycin administered during dialysis by a high-flux dialyzer.
    Nyman HA, Agarwal A, Senekjian HO, Leypoldt JK, Cheung AK.
    Hemodial Int; 2018 Jul; 22(3):383-387. PubMed ID: 29380499
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L, Chasseuil E, Rabot N, Paintaud G, François M, Birmelé B, Darrouzain F, Büchler M, Halimi JM, Ternant D.
    Nephron; 2017 Jul; 135(4):261-267. PubMed ID: 28152540
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J.
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [Abstract] [Full Text] [Related]

  • 11. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH, DeVincenzo N.
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [Abstract] [Full Text] [Related]

  • 12. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
    Sowinski KM, Mueller BA, Grabe DW, Manley HJ, Frye RF, Bailie GR, Marx MA.
    Am J Kidney Dis; 2001 Apr; 37(4):766-76. PubMed ID: 11273877
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA, Sahm DF, Umans JG.
    Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
    [Abstract] [Full Text] [Related]

  • 14. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.
    Salama NN, Segal JH, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA.
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812
    [Abstract] [Full Text] [Related]

  • 15. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ, Mueller BA.
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [Abstract] [Full Text] [Related]

  • 16. Vancomycin mass transfer characteristics of high-flux cellulosic dialysers.
    Scott MK, Mueller BA, Clark WR.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2647-53. PubMed ID: 9430866
    [Abstract] [Full Text] [Related]

  • 17. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal.
    Lucksiri A, Scott MK, Mueller BA, Hamburger RJ, Sowinski KM.
    Nephrol Dial Transplant; 2002 Sep; 17(9):1649-54. PubMed ID: 12198218
    [Abstract] [Full Text] [Related]

  • 18. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
    Crew P, Heintz SJ, Heintz BH.
    Am J Health Syst Pharm; 2015 Nov 01; 72(21):1856-64. PubMed ID: 26490819
    [Abstract] [Full Text] [Related]

  • 19. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 20. [Vancomycin dosing in hemodialysis patients].
    Castellano I, González Castillo PM, Covarsí A, Martínez Sánchez J, Suárez Santisteban MA, Gallego S, Marigliano N.
    Nefrologia; 2008 May 12; 28(6):607-12. PubMed ID: 19016633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.